ChemoCentryx
CCXI
#3191
Rank
S$5.06 B
Marketcap
$70.41
Share price
0.00%
Change (1 day)
36.67%
Change (1 year)

Revenue for ChemoCentryx (CCXI)

Revenue in 2022 (TTM): S$50.94 Million

According to ChemoCentryx's latest financial reports the company's current revenue (TTM ) is S$50.37 Million. In 2021 the company made a revenue of S$43.12 Million a decrease over the revenue in the year 2020 that were of S$85.18 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ChemoCentryx from 2011 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) S$50.94 M18.13%
2021 S$43.12 M-49.37%
2020 S$85.18 M75.75%
2019 S$48.46 M-17.25%
2018 S$58.57 M-46.92%
2017 S$0.11 B566.71%
2016 S$16.54 M
2015 N/A
2014 N/A-100%
2013 S$7.67 M15.86%
2012 S$6.62 M-83.84%
2011 S$41.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$13.01 B 25,726.61%๐Ÿ‡บ๐Ÿ‡ธ USA
S$75.20 B 149,182.26%๐Ÿ‡บ๐Ÿ‡ธ USA
S$54.51 B 108,106.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$64.23 B 127,413.44%๐Ÿ‡บ๐Ÿ‡ธ USA
S$118.76 B 235,641.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$44.05 B 87,356.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$81.40 B 161,488.71%๐Ÿ‡บ๐Ÿ‡ธ USA
S$22.71 B 44,983.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
S$85.55 B 169,722.58%๐Ÿ‡บ๐Ÿ‡ธ USA